Mary Mosher

Array ( [id] => 4404675 [patent_doc_number] => 06309647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Poxvirus--canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants' [patent_app_type] => 1 [patent_app_number] => 9/354138 [patent_app_country] => US [patent_app_date] => 1999-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 55 [patent_no_of_words] => 55732 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309647.pdf [firstpage_image] =>[orig_patent_app_number] => 354138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439364 [patent_doc_number] => 06495143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Botulinum neurotoxin vaccine' [patent_app_type] => B2 [patent_app_number] => 09/350756 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8414 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495143.pdf [firstpage_image] =>[orig_patent_app_number] => 09350756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1318007 [patent_doc_number] => 06605467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine' [patent_app_type] => B2 [patent_app_number] => 09/319264 [patent_app_country] => US [patent_app_date] => 1999-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6153 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605467.pdf [firstpage_image] =>[orig_patent_app_number] => 09319264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4266436 [patent_doc_number] => 06322793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Channel catfish virus vaccine' [patent_app_type] => 1 [patent_app_number] => 9/334181 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5213 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322793.pdf [firstpage_image] =>[orig_patent_app_number] => 334181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269943 [patent_doc_number] => 06280722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Antifungal Bacillus thuringiensis strains' [patent_app_type] => 1 [patent_app_number] => 9/333373 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5645 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280722.pdf [firstpage_image] =>[orig_patent_app_number] => 333373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1252459 [patent_doc_number] => 06669943 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals' [patent_app_type] => B1 [patent_app_number] => 09/332288 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15830 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/669/06669943.pdf [firstpage_image] =>[orig_patent_app_number] => 09332288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549289 [patent_doc_number] => 06346377 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Screening for papilloma viruses' [patent_app_type] => B1 [patent_app_number] => 09/314268 [patent_app_country] => US [patent_app_date] => 1999-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19548 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346377.pdf [firstpage_image] =>[orig_patent_app_number] => 09314268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1592804 [patent_doc_number] => 06383496 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype' [patent_app_type] => B1 [patent_app_number] => 09/314062 [patent_app_country] => US [patent_app_date] => 1999-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32605 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383496.pdf [firstpage_image] =>[orig_patent_app_number] => 09314062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1376838 [patent_doc_number] => 06555311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Viral variants and methods for detecting same' [patent_app_type] => B1 [patent_app_number] => 09/306420 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13568 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555311.pdf [firstpage_image] =>[orig_patent_app_number] => 09306420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1329674 [patent_doc_number] => 06596280 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Method for generating birnavirus from synthetic RNA transcripts' [patent_app_type] => B1 [patent_app_number] => 09/147771 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 18497 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596280.pdf [firstpage_image] =>[orig_patent_app_number] => 09147771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4348245 [patent_doc_number] => 06217882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Use of recombinant swine poxvirus as a live vaccine vector' [patent_app_type] => 1 [patent_app_number] => 9/299268 [patent_app_country] => US [patent_app_date] => 1999-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 13074 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/217/06217882.pdf [firstpage_image] =>[orig_patent_app_number] => 299268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1594033 [patent_doc_number] => 06383795 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Efficient purification of adenovirus' [patent_app_type] => B1 [patent_app_number] => 09/296962 [patent_app_country] => US [patent_app_date] => 1999-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5619 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383795.pdf [firstpage_image] =>[orig_patent_app_number] => 09296962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1588521 [patent_doc_number] => 06482632 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof' [patent_app_type] => B1 [patent_app_number] => 09/295851 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11681 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482632.pdf [firstpage_image] =>[orig_patent_app_number] => 09295851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589842 [patent_doc_number] => 06482928 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Fab-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5' [patent_app_type] => B1 [patent_app_number] => 09/289942 [patent_app_country] => US [patent_app_date] => 1999-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11848 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482928.pdf [firstpage_image] =>[orig_patent_app_number] => 09289942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 515882 [patent_doc_number] => 07189401 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-13 [patent_title] => 'Live attenuated viruses for use as vectors or vaccines' [patent_app_type] => utility [patent_app_number] => 09/647911 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5560 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189401.pdf [firstpage_image] =>[orig_patent_app_number] => 09647911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4299519 [patent_doc_number] => 06251583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Peptide substrates for HCV NS3 protease assays' [patent_app_type] => 1 [patent_app_number] => 9/288391 [patent_app_country] => US [patent_app_date] => 1999-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11919 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251583.pdf [firstpage_image] =>[orig_patent_app_number] => 288391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361677 [patent_doc_number] => 06274147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts' [patent_app_type] => 1 [patent_app_number] => 9/282147 [patent_app_country] => US [patent_app_date] => 1999-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17472 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274147.pdf [firstpage_image] =>[orig_patent_app_number] => 282147 [rel_patent_id] =>[rel_patent_doc_number] =>)